MELETA TAYLOR: Open Payments
NPI 1023116746 · MIDDLETOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,547 in 24 payments from 10 companies in 2025. Trend: 2023 $282 · 2024 $1,706 · 2025 $1,547
Food & beverage: $1,547
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $583 |
| Axsome Therapeutics, Inc. | 2 | $248 |
| Braeburn Inc. | 6 | $219 |
| Lilly USA, LLC | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Indivior Inc. | 1 | $100 |
| Merck Sharp & Dohme LLC | 1 | $58 |
| Kowa Pharmaceuticals America, Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $23 |
Products named: BREZTRI, TEZSPIRE, Auvelity, BRIXADI, ZEPBOUND, VOQUEZNA, SUBLOCADE, FARXIGA.
Industry payments across NY — which companies pay providers there.
